Among this number are big pharma firmsand Merck &Co, as well as UK-based Abbott Diagnostics, opioid addiction specialist Indivior, Tokyo-based Otsuka, detection and informatics specialist Perkin Elmer and Torax
PCM delivers healthcare communications and non-promotional medical education to a range of clients, including Novartis, Gilead and Indivior.
Vertex's CF portfolio. Royalty stream acquisition. 3, 300. Indivior / Reckitt Benckiser.
Reckitt Benckiser(RB) is spinning out its pharma business unit, under the name Indivior. ... Indivior will not be without its challenges as sales of its off-patent opioid addiction treatment Suboxone continue to slump.
The RB Pharmaceuticals (RBP) unit will be spun-off with a separate UK listing as Indivior, which will be UK domiciled and traded on the London Stock Exchange's main market ... If the demerger - which has the full backing of Reckitt Benckiser's board –
Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...